Alternatives to Longevity Bio
Longevity Bio is a Biotech tool: drug discovery platform focused on developing therapeutics for age-related diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Longevity Bio
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Sutro Biopharma40BiotechSouth San Francisco, United States$296.4MClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Vividion Therapeutics22BiotechSan Diego, United States$267.0MBiopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
- Website
Hexagon Bio57BiotechMenlo Park, United States$100.0MDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Aerska54BiotechDublin, Ireland$32.0MIrish BioTech startup Aerska raises €32 million to enable loved ones to live longer.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
Khosen Bio35Biotechירושלים, IsraelDeveloping novel therapeutic antibodies for challenging diseases.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website RERetro Biosciences48BiotechRedwood City, United States$180.0M
A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.
- Website TRTreeline Biosciences47BiotechCambridge, United States$200.0M
Developing novel therapeutics for challenging diseases using advanced biological insights.
- Website JUJuvenescence Ltd.47BiotechGeorge Town, Cayman Islands$150.0M
Biotech company focused on developing therapies to extend human healthspan and lifespan.
- Website GEGenerate:Biologics47BiotechWaltham, United States$10.0M
Develops and manufactures biologics for therapeutic applications.
- Website JUJuvenescence Uk Ltd47BiotechLondon, United Kingdom$150.0M
Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.
Showing the 20 closest matches. See the rest on the Longevity Bio profile.
Compare Longevity Bio head to head
Side by side on what each one does, what it costs, and what real users report.